Literature DB >> 9459071

Depression and self-medication with nicotine: the modifying influence of the dopamine D4 receptor gene.

C Lerman1, N Caporaso, D Main, J Audrain, N R Boyd, E D Bowman, P G Shields.   

Abstract

This study evaluated whether there are genetic subgroups of depressed individuals who are more or less predisposed to engage in self-medication smoking practices. Smokers (N = 231) completed self-report questionnaires of depression and smoking practices and were genotyped for the dopamine D4 receptor (DRD4) gene. A significant interaction (DRD4 Genotype x Depression) was found for stimulation smoking and negative-affect reduction smoking. Specifically, these smoking practices were significantly heightened in depressed smokers homozygous for the short alleles of DRD4 but not in those heterozygous or homozygous for the long alleles of DRD4. These preliminary results suggest that the rewarding effects of smoking and the beneficial effects of nicotine replacement therapy for depressed smokers may depend, in part, on genetic factors involved in dopamine transmission.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9459071     DOI: 10.1037//0278-6133.17.1.56

Source DB:  PubMed          Journal:  Health Psychol        ISSN: 0278-6133            Impact factor:   4.267


  60 in total

Review 1.  Genetics of smoking and depression.

Authors:  Ming T Tsuang; Tracee Francis; Kyle Minor; Alison Thomas; William S Stone
Journal:  Hum Genet       Date:  2012-04-17       Impact factor: 4.132

2.  Effects of nicotine deprivation and replacement on BOLD-fMRI response to smoking cues as a function of DRD4 VNTR genotype.

Authors:  Xiaomeng Xu; Uraina S Clark; Sean P David; Richard C Mulligan; Valerie S Knopik; John McGeary; James MacKillop; Jeanne McCaffery; Raymond S Niaura; Lawrence H Sweet
Journal:  Nicotine Tob Res       Date:  2014-03-22       Impact factor: 4.244

3.  Gender differences in the effect of tobacco use on brain phosphocreatine levels in methamphetamine-dependent subjects.

Authors:  Young-Hoon Sung; Deborah A Yurgelun-Todd; Douglas G Kondo; Xian-Feng Shi; Kelly J Lundberg; Tracy L Hellem; Rebekah S Huber; Erin C McGlade; Eun-Kee Jeong; Perry F Renshaw
Journal:  Am J Drug Alcohol Abuse       Date:  2015-04-14       Impact factor: 3.829

4.  Cigarette smoking and onset of mood and anxiety disorders.

Authors:  Ramin Mojtabai; Rosa M Crum
Journal:  Am J Public Health       Date:  2013-01-17       Impact factor: 9.308

5.  Depressive Symptoms and Tobacco Use: Does Religious Orientation Play a Protective Role?

Authors:  Stacy C Parenteau
Journal:  J Relig Health       Date:  2018-08

6.  Deaf patient-provider communication and lung cancer screening: Health Information National Trends survey in American Sign Language (HINTS-ASL).

Authors:  P Kushalnagar; Alina Engelman; G Sadler
Journal:  Patient Educ Couns       Date:  2018-03-05

7.  Nicotine patch vs. nicotine lozenge for smoking cessation: an effectiveness trial coordinated by the Community Clinical Oncology Program.

Authors:  Robert A Schnoll; Elisa Martinez; Kristina L Tatum; Marcella Glass; Albert Bernath; Daron Ferris; Patrick Reynolds
Journal:  Drug Alcohol Depend       Date:  2009-12-09       Impact factor: 4.492

8.  Do genetic and individual risk factors moderate the efficacy of motivational enhancement therapy? Drinking outcomes with an emerging adult sample.

Authors:  Sarah W Feldstein Ewing; Heather A LaChance; Angela Bryan; Kent E Hutchison
Journal:  Addict Biol       Date:  2009-03-05       Impact factor: 4.280

Review 9.  Future antidepressants: what is in the pipeline and what is missing?

Authors:  Fokko J Bosker; Ben H C Westerink; Thomas I F H Cremers; Marjolein Gerrits; Marieke G C van der Hart; Sjoukje D Kuipers; Gieta van der Pompe; Gert J ter Horst; Johan A den Boer; Jakob Korf
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

Review 10.  ADHD and smoking: from genes to brain to behavior.

Authors:  Francis Joseph McClernon; Scott Haden Kollins
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.